Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors
- Status
- UNKNOWN
- Phase
- PHASE4
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
- Status
- COMPLETED
- Phase
- PHASE1
Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- NA
Sequential Study to Treat Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens
- Status
- COMPLETED
- Phase
- N/A
T Regulatory Cells in Renal Cell Carcinoma (PILOT STUDY)
- Status
- COMPLETED
- Phase
- N/A
Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Body Radiotherapy (SBRT) and Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer (RCC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I Study of Vorinostat and Sorafenib in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE2